Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminophylline in acute exacerbation of COPD requiring noninvasive ventilation
IRCT20200204046374N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aminophylline in chronic obstructive pulmonary disease (COPD), sponsored by Isfahan University of Medical Sciences. Started Nov 2019; status: completed.
02
Drugs
aminophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20200204046374N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200204046374N1.